top of page

Crohn’s disease (CD)

Crohn’s disease (CD) and ulcerative colitis (UC) are both inflammatory bowel diseases (IBD). Crohn’s disease is characterized by chronic inflammation in the gastrointestinal tract, where the inflammation extends through the entire intestinal wall, from the mucosa to the outer connective tissue (serosa).

Crohns sykdom

Crohn’s disease is a serious, chronic inflammatory condition that can be challenging to diagnose and manage. The disease follows a fluctuating course with periods of exacerbation (attacks) and remission. Repeated attacks may cause the disease to progress from mild/moderate to severe, with extensive inflammation (fistula formation) or scarring (strictures). There is no cure, and most patients experience significantly reduced quality of life¹.


Causes (Etiology)

Crohns sykdom og ulcerøs kolitt

The cause of Crohn’s disease is unknown, but both genetic factors and environmental influences on the immune system play a role.

The gut microbiota in people with Crohn’s disease is altered, though it remains unclear whether this is a consequence of the inflammation or part of the cause.

A diet high in processed foods, sugary drinks, and fast food may increase risk. Crohn’s disease is not contagious².


Epidemiology

Crohn’s disease occurs most frequently in Western industrialized countries, particularly in North America, Northern Europe, and New Zealand.

The disease has a bimodal distribution: onset most often occurs at ages 15–30 and 40–60. It is more common in urban than in rural areas¹.


Symptoms and Clinical Presentation

Crohn’s disease often has a fluctuating course with periods of exacerbation (flares) and symptom-free periods (remission)³.

Common symptoms during flares:

  • Abdominal pain, especially in the lower right abdomen

  • Bloating, gas

  • Diarrhea, often with mucus and blood

  • Fever

  • Weight loss

  • Anemia

  • In acute disease: perianal abscess, perianal Crohn’s, fistulas, and rectal ulcers¹

About 50% of patients have mild symptoms, while the rest may experience more severe problems with recurrent pain and inflammatory episodes. Symptom-free periods may last months to years, but most patients experience recurrent flare-ups over time³.


Types and Localization of Crohn’s Disease

Crohn’s disease can affect different parts of the gastrointestinal tract and is categorized by location and disease pattern⁵:

  • Gastroduodenal Crohn’s: Rare, affects stomach and duodenum (about 5%)

  • Jejunoileitis: Inflammation in the jejunum (middle part of the small intestine), rare

  • Ileitis: Inflammation in the ileum (last part of the small intestine), occurs in 30%

  • Ileocolitis: Inflammation in both ileum and colon, most common (50%)

  • Crohn’s colitis: Inflammation confined to the colon, occurs in about 20%. Often associated with extraintestinal symptoms and perianal complications.

  • Perianal Crohn’s: Affects about one-third of patients, with fistulas, fissures, abscesses, or skin tags around the rectum⁶


Complications

Chrons

Crohn’s disease is a systemic condition and may lead to a variety of local and general complications:

  • Strictures, fistulas, and abscesses in the intestinal wall

  • Colorectal cancer (carcinoma)

  • Ankylosing spondylitis (inflammatory joint disease in spine and pelvis)

  • Skin conditions such as erythema nodosum and pyoderma gangrenosum

  • Kidney and gallstones

  • Anemia

  • Increased risk of blood clots (hypercoagulation)

  • Osteoporosis

  • Eye inflammations (e.g., uveitis)¹


Diagnostics

The diagnosis of Crohn’s disease is made after excluding other possible causes. Evaluation includes:

  • Blood tests

  • Test for blood in stool

  • Colonoscopy or flexible sigmoidoscopy

  • X-ray with barium enema or imaging of the small intestine

  • CT of abdomen/intestine

  • Capsule endoscopy⁶

Many patients with Crohn’s develop complications requiring surgery, often multiple times throughout life. After surgery, regular follow-up with endoscopy is recommended after 6–12 months. If no signs of recurrence, it should be repeated after 1–3 years¹.


Treatment and Follow-Up

Treatment is categorized by severity:

  • Mild to moderate disease: Treated with medications such as mesalazine (5-ASA), immunomodulators, methotrexate, and steroids.

  • Moderate to severe disease: Combination of immunomodulating drugs and/or biologics.

Other important measures:

  • Referral to a clinical dietitian for individualized nutritional guidance and supplementation before and during treatment.

  • Active disease during pregnancy increases risk of complications, and flare-ups must be treated quickly and effectively⁷.

  • Psychological support and counseling for managing depression and stress.

  • Patient education on disease and lifestyle advice:

    • Avoid NSAIDs (may worsen disease)

    • Manage mild diarrhea with antidiarrheal agents if needed

    • Avoid smoking

    • Follow dietary advice from a clinical dietitian¹


Physiotherapy

Physiotherapists play an important role, especially in managing complications such as joint and back problems, reduced bone density, and lowered physical capacity:

  • Crohn’s disease can cause joint inflammation, particularly in the lower back and sacroiliac joints. Joint problems are common, even in young patients.

  • The physiotherapist must always investigate underlying causes when patients present with back, hip, or pelvic pain, and consider possible inflammatory bowel disease.

  • The disease can reduce absorption of vital nutrients (e.g., vitamin D and calcium), increasing the risk of osteoporosis and vertebral fractures. Physiotherapists should educate patients about bone health and risk factors.

  • Dehydration may occur during exercise; physiotherapists should be alert to symptoms such as headache, dry lips, and confusion.

  • Physical activity strengthens the immune system, reduces depression, improves self-image, and supports coping. The physiotherapist should design training programs, coping strategies, and techniques to handle the unpredictability of the disease⁹.


Monitoring and Follow-Up

The Crohn’s Disease Activity Index (CDAI) is used to monitor disease progression or improvement over time. A score below 150 indicates low disease activity, while higher scores predict a worse prognosis¹⁰.


Diet

Nutritional advice should be provided by a clinical dietitian, as patient needs vary. There is much uncertainty and conflicting information, so individualized recommendations are essential².


Differential Diagnoses

Symptoms of Crohn’s disease can resemble many other conditions:

  • Amebic infection

  • Behçet’s disease

  • Celiac disease

  • Intestinal carcinoid tumor

  • Intestinal tuberculosis

  • Mesenteric ischemia

  • Ulcerative colitis


References

  1. Ranasinghe IR, Hsu R. Crohn disease. Available from: https://www.ncbi.nlm.nih.gov/books/NBK436021/ (last accessed: 1.10.2022).

  2. Crohn's and Colitis Australia. About Crohn’s Disease. Available from: https://crohnsandcolitis.org.au/about-crohns-colitis/crohns-disease/about-crohns-disease/ (last accessed: 1.10.2022).

  3. Crohn’s and Colitis Foundation of America. About Crohn’s Disease. Available from: http://ccfa.org/info/about/crohns (last accessed: 4.3.2010).

  4. Craig T. A Frank discussion on Crohn's Disease. Available from: http://www.youtube.com/watch?v=Npda8xr2G-Y (last accessed: 5.4.2010).

  5. John Hopkins Medicine. Crohn’s Disease: Introduction. Available from: http://www.hopkins-gi.org/GDL_Disease.aspx?CurrentUDV=31&GDL_Disease_ID=291F2209-F8A9-4011-8094-11EC9BF3100E&GDL_DC_ID=D03119D7-57A3-4890-A717-CF1E7426C8BA (last accessed: 5.4.2010).

  6. Cheifetz A, Moss A, Peppercorn M. Crohn’s Disease. Knol Beta. Available from: http://knol.google.com/k/crohn-s-disease# (last accessed: 5.4.2010).

  7. Kalla R, Ventham NT, Satsangi J, Arnott ID. Crohn’s disease. BMJ. 2014;349. Available from: https://www.bmj.com/content/349/bmj.g6670 (last accessed: 1.10.2022).

  8. Enzine Articles. The Link Between Crohn's Disease And Lower Back Pain. Available from: https://ezinearticles.com/?The-Link-Between-Crohns-Disease-And-Lower-Back-Pain&id=7654760 (last accessed: 1.10.2022).

  9. Goodman CC, Fuller KS. Pathophysiology: Implications for the Physical Therapist. 3rd ed. St. Louis, MO: Saunders-Elsevier; 2009.

  10. Crohn’s Disease Activity Index (CDAI). CDAI Online Calculator. Available from: http://www.ibdjohn.com/cdai/ (last accessed: 4.3.2010).

Tip: Use Ctrl + F to search on the page.

Help us keep PhysioDock free

All content on PhysioDock is free – but it costs to keep it running.

PhysioDock is built to be an open and accessible platform for physiotherapists, students, and patients alike. Here you’ll find articles, measurement tools, exercise libraries, diagnostic resources, and professional materials – all completely free.

Behind the scenes, however, there are hundreds of hours of work: research, writing, development, design, maintenance, testing, and updates. We do this because we believe in open knowledge and better health information.

If you’d like to support our work and help us continue developing and improving PhysioDock, we truly appreciate everyone who:
– subscribes to a PhysioDock+ membership
– uses and recommends PhysioDock in their work or studies
– shares PhysioDock with others

Every contribution makes a difference – and helps us keep the platform open to everyone.
Thank you for supporting PhysioDock!

Best value

PhysioDock+

NOK 199

199

Every month

PhysioDock+ gives you exclusive benefits such as discounts, AI tools, and professional resources. The membership helps you work more efficiently, stay updated, and save time and money in your daily practice.

Valid until canceled

Access to Fysio-Open

Physionews+

Quizzes

10% discount on all purchases

5% discount on "Website for Your Clinic"

50% discount on shipping

Access to PhysioDock-AI (Under development)

Partner discounts

Exclusive product discounts

Contact us

Is something incorrect?

Something missing?
Something you’d like to see added?
More recent literature?

Feel free to get in touch and let us know which article it concerns and what could be improved.
We truly appreciate your feedback!

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram

Thanks for contributing!

bottom of page